Literature DB >> 15254205

Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion.

Matthew Lopper1, Teresa Compton.   

Abstract

Human cytomegalovirus (CMV) utilizes a complex route of entry into cells that involves multiple interactions between viral envelope proteins and cellular receptors. Three conserved viral glycoproteins, gB, gH, and gL, are required for CMV-mediated membrane fusion, but little is known of how these proteins cooperate during entry (E. R. Kinzler and T. Compton, submitted for publication). The goal of this study was to begin defining the molecular mechanisms that underlie membrane fusion mediated by herpesviruses. We identified heptad repeat sequences predicted to form alpha-helical coiled coils in two glycoproteins required for fusion, gB and gH. Peptides derived from gB and gH containing the heptad repeat sequences inhibited virus entry when introduced coincident with virus inoculation onto cells or when mixed with virus prior to inoculation. Neither peptide affected binding of CMV to fibroblasts, suggesting that the peptides inhibit membrane fusion. Both gB and gH coiled-coil peptides blocked entry of several laboratory-adapted and clinical strains of human CMV, but neither peptide affected entry of murine CMV or herpes simplex virus type 1 (HSV-1). Although murine CMV and HSV-1 gB and gH have heptad repeat regions, the ability of human CMV gB and gH peptides to inhibit virus entry correlates with the specific residues that comprise the heptad repeat region. The ability of gB and gH coiled-coil peptides to inhibit virus entry independently of cell contact suggests that the coiled-coil regions of gB and gH function differently from those of class I, single-component fusion proteins. Taken together, these data support a critical role for alpha-helical coiled coils in gB and gH in the entry pathway of CMV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254205      PMCID: PMC446119          DOI: 10.1128/JVI.78.15.8333-8341.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

Authors:  M Lu; S C Blacklow; P S Kim
Journal:  Nat Struct Biol       Date:  1995-12

2.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

3.  Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.

Authors:  Q Yao; R W Compans
Journal:  Virology       Date:  1996-09-01       Impact factor: 3.616

4.  Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.

Authors:  M T Huber; T Compton
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.

Authors:  K Schoppel; E Hassfurther; W Britt; M Ohlin; C A Borrebaeck; M Mach
Journal:  Virology       Date:  1996-02-01       Impact factor: 3.616

6.  Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B.

Authors:  K A Boyle; T Compton
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.

Authors:  M Urban; M Klein; W J Britt; E Hassfurther; M Mach
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

8.  Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate.

Authors:  T Compton; D M Nowlin; N R Cooper
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

9.  Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II.

Authors:  B Kari; R Gehrz
Journal:  J Gen Virol       Date:  1993-02       Impact factor: 3.891

10.  Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system.

Authors:  A Turner; B Bruun; T Minson; H Browne
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more
  48 in total

1.  Glycoprotein B of herpes simplex virus 2 has more than one intracellular conformation and is altered by low pH.

Authors:  Martin I Muggeridge
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

2.  Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion.

Authors:  Liguo Wu; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2007-02-20       Impact factor: 3.616

3.  Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion.

Authors:  Tatiana Gianni; Romana Fato; Christian Bergamini; Giorgio Lenaz; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  The presence of a single N-terminal histidine residue enhances the fusogenic properties of a Membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H.

Authors:  Stefania Galdiero; Annarita Falanga; Mariateresa Vitiello; Luca Raiola; Luigi Russo; Carlo Pedone; Carla Isernia; Massimiliano Galdiero
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

5.  Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts.

Authors:  Simone Spaderna; Barbara Kropff; Yvonne Ködel; Siyuan Shen; Scott Coley; Shan Lu; William Britt; Michael Mach
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.

Authors:  Tina M Cairns; Marie S Shaner; Yi Zuo; Manuel Ponce-de-Leon; Isabelle Baribaud; Roselyn J Eisenberg; Gary H Cohen; J Charles Whitbeck
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Analysis of Epstein-Barr virus glycoprotein B functional domains via linker insertion mutagenesis.

Authors:  Jessica J Reimer; Marija Backovic; Charuhas G Deshpande; Theodore Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

8.  Analysis of a membrane interacting region of herpes simplex virus type 1 glycoprotein H.

Authors:  Stefania Galdiero; Annarita Falanga; Mariateresa Vitiello; Luca Raiola; Roberto Fattorusso; Helena Browne; Carlo Pedone; Carla Isernia; Massimiliano Galdiero
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

9.  Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice.

Authors:  Laurent Gillet; Michael B Gill; Susanna Colaco; Christopher M Smith; Philip G Stevenson
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

10.  Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL.

Authors:  Tirumala K Chowdary; Tina M Cairns; Doina Atanasiu; Gary H Cohen; Roselyn J Eisenberg; Ekaterina E Heldwein
Journal:  Nat Struct Mol Biol       Date:  2010-07-04       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.